In blood plasma production, safe blood fractionation processes hinge on tributyl phosphate. This chemical inactivates viruses by disrupting their lipid coats, thus preventing them from irrupting and infecting cells. As a result, tributyl phosphate plays a key role in destroying viruses such as HIV as well as hepatitis B and C. If you’d like to produce blood plasma without worrying about quality, meeting regulatory requirements, or losing time on documentation, you’ll want to take advantage of Tributyl phosphate EMPROVE® bio Ph Eur, the latest addition to the Merck EMPROVE® bio portfolio.

High quality and compliance go hand in hand

Blood plasma and compounds which can be isolated from it, such as clotting factors, are key ingredients of many life-saving pharmaceuticals. Yet pharmaceutical – particularly biopharmaceutical – production calls for especially stringent production standards. That’s why we designed our EMPROVE® bio line specifically for biopharmaceutical production. As you’ve come to expect from all Merck products, Tributyl phosphate EMPROVE® bio Ph Eur is of the highest quality. And since this chemical complies with every regulation applicable to blood fractionation processes, you can rest assured that your processes will run smoothly.

Documentation is taken care of

When you use Tributyl phosphate EMPROVE® bio Ph Eur, you won’t have to spend time creating your own documentation. The chemical belongs to the EMPROVE® bio range, so the regulatory and quality data you need have already been prepared! This frees you up to focus on important research. When you refer to the documentation, you’ll find the information easy to navigate and in a standard format. All of our EMPROVE® dossiers are based on the internationally accepted Common Technical Document Module 3.

For more information on our EMPROVE® dossiers, visit www.emprove.merck.de

To learn more about Merck’s new Tributyl phosphate EMPROVE® bio Ph Eur, please contact us today.